Provectus Biopharmaceuticals, Inc. (OTCMKTS:PVCT – Get Free Report) was the target of a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 500 shares, a decline of 87.8% from the May 31st total of 4,100 shares. Based on an average trading volume of 290,100 shares, the short-interest ratio is presently 0.0 days.
Provectus Biopharmaceuticals Stock Performance
OTCMKTS PVCT traded down $0.01 on Friday, hitting $0.13. 319,198 shares of the company’s stock traded hands, compared to its average volume of 112,411. Provectus Biopharmaceuticals has a 1-year low of $0.06 and a 1-year high of $0.22. The firm’s 50-day moving average price is $0.18 and its two-hundred day moving average price is $0.15.
Provectus Biopharmaceuticals Company Profile
Read More
- Five stocks we like better than Provectus Biopharmaceuticals
- 3 Grocery Stocks That Are Proving They Are Still Essential
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- How Technical Indicators Can Help You Find Oversold Stocks
- MarketBeat Week in Review – 6/24 – 6/28
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Provectus Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Provectus Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.